# HBM BioVentures: portfolio, investments and team > HBM BioVentures is a growth equity. 60 investments on record, latest Nov 2013. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/hbm-bioventures (Millionrounds; every figure on the page links to its filing or article) [Investor](https://millionrounds.com/investors) # HBM BioVentures Last cheque observed Nov 2013. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Quiet Growth equity Series B Series C Series A Cheques on record **0%** of best year **0** **cheques in 12 months**, 60 on record Since the last cheque **4738** days **00** hrs **00** min **00** sec Median round **$25M** Rounds led **0 of 60** Sole investor **1 rounds** Exits **7 from the portfolio** Mostly in **United States, 72%** Pitch HBM BioVentures ## HBM BioVentures highlights - 01 60 rounds on record - 02 Mostly Series B and Series C: 47% of its rounds - 03 Sole investor in 1 rounds, median $1.9M - 04 7 exits from the portfolio ## What they do - **Type:** Growth equity (from a list, unverified) - **Cheque size:** Not stated - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **60 appearances** - **2013** 1 round - **Nov** **[Delenex Therapeutics](https://millionrounds.com/company/delenex-therapeutics)** Series A · CH · startupticker.ch **$8.0M** With 4 others - **2012** 2 rounds - **Jul** **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Growth · US · finsmes.com **$30M** With 4 others - **Jan** **[Probiodrug](https://millionrounds.com/company/probiodrug)** Venture · DE · finsmes.com **$19M** With 5 others - **2011** 2 rounds - **Aug** **[Ellipse Technologies](https://millionrounds.com/company/ellipse-technologies)** Series C · US · finsmes.com **$18M** With 3 others - **May** **[Delenex Therapeutics](https://millionrounds.com/company/delenex-therapeutics)** Series A · CH · finsmes.com **$19M** With 5 others - **2010** 6 rounds - **Nov** **[Vivacta](https://millionrounds.com/company/vivacta)** GB · finsmes.com **$6.4M** With 3 others - **Nov** **[Delenex Therapeutics](https://millionrounds.com/company/delenex-therapeutics)** Series A · CH · finsmes.com **$14M** With 4 others - **Nov** **[MTM Laboratories](https://millionrounds.com/company/mtm-laboratories)** Series C · US · finsmes.com **$9.7M** With 2 others - **Sept** **[Cylene Pharmaceuticals](https://millionrounds.com/company/cylene-pharmaceuticals)** Series D · US · socaltech.com **$12M** With 6 others - **Jun** **[Nereus Pharmaceuticals](https://millionrounds.com/company/nereus-pharmaceuticals)** Series E · US · onbiovc.com **$20M** With 6 others - **Jan** **[Nabriva Therapeutics](https://millionrounds.com/company/nabriva-therapeutics)** Series B · AT · onbiovc.com **$22M** With 7 others - **2009** 8 rounds - **Dec** **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Series E · US · finsmes.com **$50M** With 4 others - **Dec** **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Growth · US **$50M** With 4 others - **Dec** **[Ophthotech](https://millionrounds.com/company/ophthotech)** Series B · US · fiercebiotech.com **$30M** With 3 others - **Nov** **[Probiodrug](https://millionrounds.com/company/probiodrug)** Series B · DE · probiodrug.de **$54M** With 7 others - **Oct** **[Kolltan Pharmaceuticals](https://millionrounds.com/company/kolltan-pharmaceuticals)** Series A · US · onbiovc.com **$5.0M** With 1 other - **Oct** **[MTM Laboratories](https://millionrounds.com/company/mtm-laboratories)** Series C · US · mtmlabs.com **$57M** With 3 others - **Oct** **[Lux Biosciences](https://millionrounds.com/company/lux-biosciences)** Series B · US · venturebeat.com **$50M** With 3 others - **Aug** **[Zosano Pharma](https://millionrounds.com/company/zosano-pharma)** Series B · US · onbiovc.com **$30M** With 3 others - **2008** 5 rounds - **Aug** **[ESBATech](https://millionrounds.com/company/esbatech)** Series B · CH · fiercebiotech.com **$22M** With 7 others - **Jul** **[Kolltan Pharmaceuticals](https://millionrounds.com/company/kolltan-pharmaceuticals)** Series A · US **$40M** With 4 others - **Jul** **[Broncus Technologies, Inc.](https://millionrounds.com/company/broncus-technologies-inc)** Debt · US **Undisclosed** With 2 others - **Jul** **[MiCardia Corporation](https://millionrounds.com/company/micardia-corporation)** Venture · US **$5.0M** With 1 other - **Jan** **[Genizon BioSciences](https://millionrounds.com/company/genizon-biosciences)** Series E · CA · genizon.com **$31M** With 3 others - **2007** 15 rounds - **Dec** **[Pelikan Technologies](https://millionrounds.com/company/pelikan-technologies)** Series F · US · venturebeat.com **$69M** With 2 others - **Nov** **[Vivacta](https://millionrounds.com/company/vivacta)** Series B · GB **$12M** With 3 others - **Nov** **[Zosano Pharma](https://millionrounds.com/company/zosano-pharma)** Series A · US · zosanopharma.com **$90M** With 3 others - **Nov** **[Sloning BioTechnology](https://millionrounds.com/company/sloning-biotechnology)** Series E · DE · sloning.com **$6.8M** With 3 others - **Oct** **[Vital Therapies](https://millionrounds.com/company/vital-therapies)** Series C · US **$28M** With 3 others - **Aug** **[Ophthotech](https://millionrounds.com/company/ophthotech)** Series A · US **$36M** With 2 others - **Aug** **[Nereus Pharmaceuticals](https://millionrounds.com/company/nereus-pharmaceuticals)** Series D · US **$45M** With 12 others - **Aug** **[Adnexus](https://millionrounds.com/company/adnexus)** Series C · US · adnexustx.com **$16M** With 4 others - **Jul** **[Agensys](https://millionrounds.com/company/agensys)** Series D · US · agensys.com **$41M** With 10 others - **May** **[Interventional Spine](https://millionrounds.com/company/interventional-spine)** Series C · US **$24M** With 3 others - **May** **[BaroFold](https://millionrounds.com/company/barofold)** Series A · US · venturebeat.com **$12M** With 2 others - **Mar** **[Surface Logix](https://millionrounds.com/company/surface-logix)** Series D · US **$20M** With 4 others - **Mar** **[ChemoCentryx](https://millionrounds.com/company/chemocentryx)** Series D · US · deals.venturebeat.com **$30M** With 4 others - **Feb** **[Locus Pharmaceuticals](https://millionrounds.com/company/locus-pharmaceuticals)** Series E · US **$30M** With 3 others - **Jan** **[Cylene Pharmaceuticals](https://millionrounds.com/company/cylene-pharmaceuticals)** Series C · US · rctech.com **$44M** With 7 others - **2006** 5 rounds - **Dec** **[Cathay Industrial Biotech](https://millionrounds.com/company/cathay-industrial-biotech)** Series B **$52M** With 4 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## Exits from the portfolio Companies it backed that were later bought or listed **7 in all** **[PTC Therapeutics](https://millionrounds.com/company/ptc-therapeutics)** Listed **$125M** Jun 2013 **[MTM Laboratories](https://millionrounds.com/company/mtm-laboratories)** Bought by Roche **Undisclosed** Jul 2011 **[Surface Logix](https://millionrounds.com/company/surface-logix)** Bought by Nano Terra **Undisclosed** Apr 2011 **[Sloning BioTechnology](https://millionrounds.com/company/sloning-biotechnology)** Bought by [MorphoSys](https://millionrounds.com/fund/morphosys) **Undisclosed** Oct 2010 **[Adnexus](https://millionrounds.com/company/adnexus)** Bought by [Bristol-Myers Squibb](https://millionrounds.com/fund/bristol-myers-squibb) **$415M** Aug 2010 **[Biovitrum](https://millionrounds.com/company/biovitrum)** Bought by [Swedish Orphan Biovitrum](https://millionrounds.com/fund/swedish-orphan-biovitrum) **$493M** Nov 2009 **[Adnexus](https://millionrounds.com/company/adnexus)** Bought by [Bristol-Myers Squibb](https://millionrounds.com/fund/bristol-myers-squibb) **$415M** Sept 2007 An exit counts when it came after the firm's first round in the company. From historical deal records. ## Companies it bought Acquisitions by the firm itself **New Medical Technologies** **Undisclosed** Feb 2003 ## The cheque Series B Series C Series A Median round joined **$25M** the round, not its cheque Alone, median **$1.9M** Led 0 of 60 rounds **0%** - **Sole investor:** 1 rounds - **Last cheque:** Nov 2013 - **Exits:** 7 from the portfolio Rounds by stage said on their site - Series B *16* - Series C *9* - Series A *8* - Venture *7* - Series E *7* - Series D *6* Cheques by year Led Joined 2001 2013 Often in the room with - [Alta Partners](https://millionrounds.com/fund/alta-partners) 10 - [Novo Holdings A/S](https://millionrounds.com/fund/novo-holdings-a-s) 10 - [SV Life Sciences](https://millionrounds.com/fund/sv-life-sciences) 9 - [Delphi Ventures](https://millionrounds.com/fund/delphi-ventures) 7 - [HBM BioCapital](https://millionrounds.com/fund/hbm-biocapital) 6 - [BioMedPartners](https://millionrounds.com/fund/biomedpartners) 5 **Pitching HBM BioVentures?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as HBM BioVentures. A count of rooms they were both in, not a relationship either has claimed. [**Alta Partners** VC firm **10** rounds together](https://millionrounds.com/fund/alta-partners)[**Novo Holdings A/S** Growth equity **10** rounds together](https://millionrounds.com/fund/novo-holdings-a-s)[**SV Life Sciences** VC firm **9** rounds together](https://millionrounds.com/fund/sv-life-sciences)[**Delphi Ventures** VC firm **7** rounds together](https://millionrounds.com/fund/delphi-ventures)[**HBM BioCapital** Investment firm **6** rounds together](https://millionrounds.com/fund/hbm-biocapital)[**BioMedPartners** Private equity **5** rounds together](https://millionrounds.com/fund/biomedpartners)[**Gimv** Private equity **5** rounds together](https://millionrounds.com/fund/gimv)[**MedFocus Fund** Fund of funds **5** rounds together](https://millionrounds.com/fund/medfocus-fund)[**Novartis Venture Fund** Corporate VC **5** rounds together](https://millionrounds.com/fund/novartis-venture-fund)[**OrbiMed** Private equity **5** rounds together](https://millionrounds.com/fund/orbimed)[**VI Partners** VC firm **5** rounds together](https://millionrounds.com/fund/vi-partners)[**Clarus Ventures** VC firm **4** rounds together](https://millionrounds.com/fund/blackstone) ## Quick answers about HBM BioVentures ### What does HBM BioVentures invest in? HBM BioVentures invests most often at Series B and Series C (47% of the rounds on record). ### How active is HBM BioVentures? 60 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2013. ### How big are HBM BioVentures's cheques? The median round it joins is $25M. ### Does HBM BioVentures lead rounds? Rarely, if at all: none of its 60 investments on record names it as the lead. ### Where does HBM BioVentures invest? Most of the companies it backs are in the United States (72%), Switzerland (10%) and Germany (8%). ### Is HBM BioVentures investing now? No investments in the last 12 months; the latest was in Nov 2013. ### Who does HBM BioVentures invest alongside? Most often Alta Partners (10 rounds together), Novo Holdings A/S (10 rounds together) and SV Life Sciences (9 rounds together). ### What kind of investor is HBM BioVentures? HBM BioVentures is a growth equity firm. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=hbm-bioventures) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=hbm-bioventures)